Hepatocellular carcinoma is a tumor with a high incidence and high mortality. These data .. manejo del CHC celebrada en Barcelona en el an˜o definieron por vez primera .. hepática (clasificación Child-Pugh) y presencia de sıntomas. The present manuscript depicts the Barcelona‐Clínic Liver Cancer Group diagnostic and treatment strategy. This is based on the analysis of. The value of the Barcelona Clinic Liver Cancer and alpha-fetoprotein in the Conclusiones: nuestros resultados confirman que la clasificación BCLC es un.

Author: Jusar Vigami
Country: Saint Kitts and Nevis
Language: English (Spanish)
Genre: Marketing
Published (Last): 27 August 2013
Pages: 177
PDF File Size: 11.14 Mb
ePub File Size: 6.31 Mb
ISBN: 369-1-31769-517-9
Downloads: 47773
Price: Free* [*Free Regsitration Required]
Uploader: Zologor

A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma. N Engl J Med. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatocellular carcinoma in cirrhosis: Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis.

Heterogeneity among different studies may reflect both inclusion of patients with different stages of disease and variability in the molecular characteristics and biological behavior of the tumor. During the follow-up period, 59 patients Hepatocellular carcinoma HCC is the most common primary liver malignancy 1 and is the major cause of deaths in patients with cirrhosis 2,3.

The EASL panel of experts recommended the consideration of four related aspects: Patients and methods This observational study was approved by the Institutional Review Board of our hospital. There is only one prospective trial globally validating the BCLC system Aliment Pharmacol Ther ; The figure 3 shows the survival curves according the serum AFP.


Colombo M, Sangiovanni A.

A total of 86 patients Our current level of knowledge prevents recommendation of a staging system to be used worldwide. Investigators in Hong Kong described a staging system analysing their experience in patients, most of clasificavion with HBV-related cirrhosis The BCLC staging system may discriminate patients at early stages, and guide the treatment strategy.

Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: The Cox proportional hazards model was used for the multivariate analysis.

A recent comparison with other staging systems has shown that it has limited prognostic capacity in patients with early HCC Please review our privacy policy. The mean follow-up period of clasificzcion patients was Univariate survival curves were estimated using the Kaplan-Meier method; the differences in the survival rates between the groups were compared using the log-rank test.

The natural history of this neoplasm is not completely known.

Eur J Gastroenterol Hepatol. Both diseases may lead to death. Outcomes of dysplastic nodules in human cirrhotic liver: Most patients had Child-Pugh class A It could se aid in the management of HCC patients on waiting list or in the election of the best possible treatment for those patients.

The current knowledge of the disease, however, prevents recommendation of a staging system that can be used world-wide.


Staging systems in hepatocellular carcinoma

Trends in survival hepatocwrcinoma patients with hepatocellular carcinoma between and in United States The critical issue of hepatocellular carcinoma prognostic classification: Second, early diagnosis of HCC still relies on pathological data rather than molecular data, and thus the accuracy hepatocarcino,a differentiating premalignant lesions and early neoplasm is still ill defined.

The 1, 2, 3, 4 and 5 year survival rate was Several additional investigations to identify variables related to prognosis in many countries have been published in the last years. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance.

National Center for Biotechnology InformationU. In the report of Grieco 35the median survival was Dysplastic nodules and hepatocarcinogenesis.

Staging systems in hepatocellular carcinoma

A total of 23 patients How should patients with hepatocellular carcinoma be staged? Management of hepatocellular carcinoma. LlovetSenior Scientist 1 2. Finally, once diagnosis is established, the prognosis of patients will vary according to the evolutionary stage at which the neoplasm is diagnosed and the treatment received.

These figures have also been recently reproduced when analysing survival estimates gathered from population-based cancer registries When clinically indicated, we used a combined treatment.

Posted in Art